Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Biomea Fusion, Inc.BMEA · Entity 6606 | Director · See Remarks | April 01, 2026 | April 03, 2026 |
| POLARITYTE, INC.PTE · Entity 117561 | Director | January 02, 2020 | January 06, 2020 |
| Summit Therapeutics Inc.SMMT · Entity 3477 | Director | February 19, 2021 | February 23, 2021 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Biomea Fusion, Inc.
Report date April 01, 2026 · Filed April 03, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $1.49 · Expires 2036-03-31 | Direct | 452,512 |
Reported balance
After 2026-04-01 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-04-01 · Grant · Acquired 452,512 · Balance 452,512 F1: The option shall vest and become exercisable in 16 substantially equal quarterly installments after April 1, 2026, such that the award will be fully vested and exercisable on April 1, 2030, subject to the Reporting Person's continued service to the Issuer through each vesting date. |
Filing footnotes · ownership attribution and instrument terms
F1: The option shall vest and become exercisable in 16 substantially equal quarterly installments after April 1, 2026, such that the award will be fully vested and exercisable on April 1, 2030, subject to the Reporting Person's continued service to the Issuer through each vesting date.
POLARITYTE, INC.
Report date January 02, 2020 · Filed January 06, 2020
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock option(Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $2.60 · Expires 2030-01-31 | Direct | 38,437 |
Reported balance
After 2020-01-02 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2020-01-02 · Grant · Acquired 38,437 · Balance 38,437 F1: This option was issued to the reporting person pursuant to the 2019 Equity Incentive Plan for annual director fees in the amount of $80,000. |
Filing footnotes · ownership attribution and instrument terms
F1: This option was issued to the reporting person pursuant to the 2019 Equity Incentive Plan for annual director fees in the amount of $80,000.
Summit Therapeutics Inc.
Report date February 19, 2021 · Filed February 23, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $7.33 · Expires 2031-02-19 | Direct | 252,273 |
Reported balance
After 2021-02-19 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2021-02-19 · Grant · Acquired 25,000 · Balance 252,273 F2: Not applicable. F1: The option was granted on February 19, 2021. The shares underlying the option are scheduled to vest in full on December 31, 2021. |
Filing footnotes · ownership attribution and instrument terms
F1: The option was granted on February 19, 2021. The shares underlying the option are scheduled to vest in full on December 31, 2021.
F2: Not applicable.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 01, 2026 Filed Apr 3, 2026 20:15 UTC | Biomea Fusion, Inc. BMEA · Entity 6606 | GrantStock Option (Right to Buy) · Derivative | 452,512 | $0.00 Strike: $1.49 | $0.00 |
DisclosureSEC source: 0001193125-26-142178 · ownership.xml · derivative · entry 1 Erdtmann Rainer M · CIK 0001455767 · Director · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 452,512 Underlying: Common Stock · 452,512 shares Expires 2036-03-31 F1 · derivative.exercise_date: The option shall vest and become exercisable in 16 substantially equal quarterly installments after April 1, 2026, such that the award will be fully vested and exercisable on April 1, 2030, subject to the Reporting Person's continued service to the Issuer through each vesting date. Read SEC document |
| December 31, 2025 Filed Feb 6, 2026 21:15 UTC | Biomea Fusion, Inc. BMEA · Entity 6606 | GiftCommon Stock | 50,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-041207 · ownership.xml · nonDerivative · entry 6 Erdtmann Rainer M · CIK 0001455767 · Director · See Remarks 10b5-1 filing: No plan indicated Ownership: Indirect · By daughter Disclosed balance after: 70,000 Read SEC document |
| December 31, 2025 Filed Feb 6, 2026 21:15 UTC | Biomea Fusion, Inc. BMEA · Entity 6606 | GiftCommon Stock | 50,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-041207 · ownership.xml · nonDerivative · entry 5 Erdtmann Rainer M · CIK 0001455767 · Director · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 572,427 Read SEC document |
| December 31, 2025 Filed Feb 6, 2026 21:15 UTC | Biomea Fusion, Inc. BMEA · Entity 6606 | GiftCommon Stock | 50,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-041207 · ownership.xml · nonDerivative · entry 4 Erdtmann Rainer M · CIK 0001455767 · Director · See Remarks 10b5-1 filing: No plan indicated Ownership: Indirect · By son Disclosed balance after: 70,000 Read SEC document |
| December 31, 2025 Filed Feb 6, 2026 21:15 UTC | Biomea Fusion, Inc. BMEA · Entity 6606 | GiftCommon Stock | 50,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-041207 · ownership.xml · nonDerivative · entry 3 Erdtmann Rainer M · CIK 0001455767 · Director · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 622,427 Read SEC document |
| December 31, 2025 Filed Feb 6, 2026 21:15 UTC | Biomea Fusion, Inc. BMEA · Entity 6606 | GiftCommon Stock | 50,600 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-041207 · ownership.xml · nonDerivative · entry 2 Erdtmann Rainer M · CIK 0001455767 · Director · See Remarks 10b5-1 filing: No plan indicated Ownership: Indirect · By daughter Disclosed balance after: 70,000 Read SEC document |
| December 31, 2025 Filed Feb 6, 2026 21:15 UTC | Biomea Fusion, Inc. BMEA · Entity 6606 | GiftCommon Stock | 50,600 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-041207 · ownership.xml · nonDerivative · entry 1 Erdtmann Rainer M · CIK 0001455767 · Director · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 672,427 Read SEC document |
| December 11, 2025 Filed Dec 15, 2025 21:15 UTC | Biomea Fusion, Inc. BMEA · Entity 6606 | PurchaseCommon Stock | 30,000 | $1.43 | $42,999.00 |
DisclosureSEC source: 0001193125-25-319222 · ownership.xml · nonDerivative · entry 1 Erdtmann Rainer M · CIK 0001455767 · Director · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 723,027 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.42 to $1.46, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range. Read SEC document |
| December 01, 2025 Filed Dec 2, 2025 21:15 UTC | Biomea Fusion, Inc. BMEA · Entity 6606 | PurchaseCommon Stock | 10,000 | $1.05 | $10,500.00 |
DisclosureSEC source: 0001193125-25-305287 · ownership.xml · nonDerivative · entry 2 Erdtmann Rainer M · CIK 0001455767 · Director · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 693,027 Read SEC document |
| November 28, 2025 Filed Dec 2, 2025 21:15 UTC | Biomea Fusion, Inc. BMEA · Entity 6606 | PurchaseCommon Stock | 40,000 | $1.10 | $44,052.00 |
DisclosureSEC source: 0001193125-25-305287 · ownership.xml · nonDerivative · entry 1 Erdtmann Rainer M · CIK 0001455767 · Director · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 683,027 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.09 to $1.1099, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range. Read SEC document |
| August 11, 2025 Filed Aug 13, 2025 20:15 UTC | Biomea Fusion, Inc. BMEA · Entity 6606 | GrantStock Option (Right to Buy) · Derivative | 1,246,989 | $0.00 Strike: $1.53 | $0.00 |
DisclosureSEC source: 0000950170-25-108041 · ownership.xml · derivative · entry 12 Erdtmann Rainer M · CIK 0001455767 · Director · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,246,989 Underlying: Common Stock · 1,246,989 shares Expires 2035-08-10 F5 · derivative.exercise_date: The option shall vest and become exercisable in 16 substantially equal quarterly installments after August 8, 2025, such that the award will be fully vested and exercisable on August 8, 2029, subject to the Reporting Person's continued service to the Issuer through each vesting date. Read SEC document |
| January 31, 2025 Filed Aug 13, 2025 20:15 UTC | Biomea Fusion, Inc. BMEA · Entity 6606 | GiftCommon Stock | 10,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-108041 · ownership.xml · nonDerivative · entry 7 Erdtmann Rainer M · CIK 0001455767 · Director · See Remarks 10b5-1 filing: No plan indicated Ownership: Indirect · By daughter Disclosed balance after: 20,000 Read SEC document |
| January 31, 2025 Filed Aug 13, 2025 20:15 UTC | Biomea Fusion, Inc. BMEA · Entity 6606 | GiftCommon Stock | 10,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-108041 · ownership.xml · nonDerivative · entry 6 Erdtmann Rainer M · CIK 0001455767 · Director · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 643,027 Read SEC document |
| January 31, 2025 Filed Aug 13, 2025 20:15 UTC | Biomea Fusion, Inc. BMEA · Entity 6606 | GiftCommon Stock | 10,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-108041 · ownership.xml · nonDerivative · entry 5 Erdtmann Rainer M · CIK 0001455767 · Director · See Remarks 10b5-1 filing: No plan indicated Ownership: Indirect · By son Disclosed balance after: 20,000 Read SEC document |
| January 31, 2025 Filed Aug 13, 2025 20:15 UTC | Biomea Fusion, Inc. BMEA · Entity 6606 | GiftCommon Stock | 10,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-108041 · ownership.xml · nonDerivative · entry 4 Erdtmann Rainer M · CIK 0001455767 · Director · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 653,027 Read SEC document |
| January 31, 2025 Filed Aug 13, 2025 20:15 UTC | Biomea Fusion, Inc. BMEA · Entity 6606 | GiftCommon Stock | 10,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-108041 · ownership.xml · nonDerivative · entry 3 Erdtmann Rainer M · CIK 0001455767 · Director · See Remarks 10b5-1 filing: No plan indicated Ownership: Indirect · By daughter Disclosed balance after: 19,400 Read SEC document |
| January 31, 2025 Filed Aug 13, 2025 20:15 UTC | Biomea Fusion, Inc. BMEA · Entity 6606 | GiftCommon Stock | 10,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-108041 · ownership.xml · nonDerivative · entry 2 Erdtmann Rainer M · CIK 0001455767 · Director · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 663,027 Read SEC document |
| January 28, 2025 Filed Aug 13, 2025 20:15 UTC | Biomea Fusion, Inc. BMEA · Entity 6606 | GiftCommon Stock | 40,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-108041 · ownership.xml · nonDerivative · entry 1 Erdtmann Rainer M · CIK 0001455767 · Director · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 673,027 Read SEC document |
| January 17, 2024 Filed Jan 18, 2024 21:30 UTC | Biomea Fusion, Inc. BMEA · Entity 6606 | GrantStock Option (Right to Buy) · Derivative | 135,700 | $0.00 Strike: $14.44 | $0.00 |
DisclosureSEC source: 0000950170-24-005415 · ownership.xml · derivative · entry 1 Erdtmann Rainer M · CIK 0001455767 · Director · President and COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 135,700 Underlying: Common Stock · 135,700 shares Expires 2034-01-16 F1 · derivative.exercise_date: The option shall vest and become exercisable in quarterly installments over four years, subject to the Reporting Person's continued service to the Issuer through each vesting date. Read SEC document |
| December 29, 2023 Filed Jan 3, 2024 21:30 UTC | Biomea Fusion, Inc. BMEA · Entity 6606 | GiftCommon Stock | 12,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-000956 · ownership.xml · nonDerivative · entry 7 Erdtmann Rainer M · CIK 0001455767 · Director · President and COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 713,027 F1 · ownership.direct: Includes 76,059 shares held directly by the Reporting Person and the remaining shares are held directly by the Reporting Person through a family trust of which the Reporting Person is the trustee. The Reporting Person disclaims beneficial ownership of the securities reported herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of his pecuniary interest therein, if any. This report shall not be deemed an admission that the Reporting Person is a beneficial owner of such securities for the purpose of Section 16 of the Exchange Act, or for any other purpose. Read SEC document |
| December 29, 2023 Filed Jan 3, 2024 21:30 UTC | Biomea Fusion, Inc. BMEA · Entity 6606 | GiftCommon Stock | 3,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-000956 · ownership.xml · nonDerivative · entry 6 Erdtmann Rainer M · CIK 0001455767 · Director · President and COO 10b5-1 filing: No plan indicated Ownership: Indirect · By daughter Disclosed balance after: 10,000 Read SEC document |
| December 29, 2023 Filed Jan 3, 2024 21:30 UTC | Biomea Fusion, Inc. BMEA · Entity 6606 | GiftCommon Stock | 3,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-000956 · ownership.xml · nonDerivative · entry 5 Erdtmann Rainer M · CIK 0001455767 · Director · President and COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 725,027 F1 · ownership.direct: Includes 76,059 shares held directly by the Reporting Person and the remaining shares are held directly by the Reporting Person through a family trust of which the Reporting Person is the trustee. The Reporting Person disclaims beneficial ownership of the securities reported herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of his pecuniary interest therein, if any. This report shall not be deemed an admission that the Reporting Person is a beneficial owner of such securities for the purpose of Section 16 of the Exchange Act, or for any other purpose. Read SEC document |
| December 29, 2023 Filed Jan 3, 2024 21:30 UTC | Biomea Fusion, Inc. BMEA · Entity 6606 | GiftCommon Stock | 3,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-000956 · ownership.xml · nonDerivative · entry 4 Erdtmann Rainer M · CIK 0001455767 · Director · President and COO 10b5-1 filing: No plan indicated Ownership: Indirect · By son Disclosed balance after: 10,000 Read SEC document |
| December 29, 2023 Filed Jan 3, 2024 21:30 UTC | Biomea Fusion, Inc. BMEA · Entity 6606 | GiftCommon Stock | 3,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-000956 · ownership.xml · nonDerivative · entry 3 Erdtmann Rainer M · CIK 0001455767 · Director · President and COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 728,027 F1 · ownership.direct: Includes 76,059 shares held directly by the Reporting Person and the remaining shares are held directly by the Reporting Person through a family trust of which the Reporting Person is the trustee. The Reporting Person disclaims beneficial ownership of the securities reported herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of his pecuniary interest therein, if any. This report shall not be deemed an admission that the Reporting Person is a beneficial owner of such securities for the purpose of Section 16 of the Exchange Act, or for any other purpose. Read SEC document |
| December 29, 2023 Filed Jan 3, 2024 21:30 UTC | Biomea Fusion, Inc. BMEA · Entity 6606 | GiftCommon Stock | 3,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-000956 · ownership.xml · nonDerivative · entry 2 Erdtmann Rainer M · CIK 0001455767 · Director · President and COO 10b5-1 filing: No plan indicated Ownership: Indirect · By daughter Disclosed balance after: 9,400 Read SEC document |
| December 29, 2023 Filed Jan 3, 2024 21:30 UTC | Biomea Fusion, Inc. BMEA · Entity 6606 | GiftCommon Stock | 3,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-000956 · ownership.xml · nonDerivative · entry 1 Erdtmann Rainer M · CIK 0001455767 · Director · President and COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 731,027 F1 · ownership.direct: Includes 76,059 shares held directly by the Reporting Person and the remaining shares are held directly by the Reporting Person through a family trust of which the Reporting Person is the trustee. The Reporting Person disclaims beneficial ownership of the securities reported herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of his pecuniary interest therein, if any. This report shall not be deemed an admission that the Reporting Person is a beneficial owner of such securities for the purpose of Section 16 of the Exchange Act, or for any other purpose. Read SEC document |
| January 06, 2023 Filed Jan 10, 2023 22:00 UTC | Biomea Fusion, Inc. BMEA · Entity 6606 | GrantStock Option (Right to Buy) · Derivative | 118,000 | $0.00 Strike: $7.05 | $0.00 |
DisclosureSEC source: 0000899243-23-001487 · doc4.xml · derivative · entry 1 Erdtmann Rainer M · CIK 0001455767 · Director · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 118,000 Underlying: Common Stock · 118,000 shares Expires 2033-01-05 F1 · derivative.exercise_date: The option shall vest and become exercisable in quarterly installments over four years, subject to the Reporting Person's continued service to the Issuer through each vesting date. Read SEC document |
| December 28, 2022 Filed Feb 10, 2023 21:20 UTC | Biomea Fusion, Inc. BMEA · Entity 6606 | GiftCommon Stock | 70,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-23-004578 · doc5.xml · nonDerivative · entry 10 Erdtmann Rainer M · CIK 0001455767 · Director · President & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 734,027 F2 · ownership.direct: Includes 76,059 shares held directly by the Reporting Person and the remaining shares are held directly by the Reporting Person through a family trust of which the Reporting Person is the trustee. The Reporting Person disclaims beneficial ownership of the securities reported herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of his pecuniary interest therein, if any. This report shall not be deemed an admission that the Reporting Person is a beneficial owner of such securities for the purpose of Section 16 of the Exchange Act, or for any other purpose. Read SEC document |
| December 28, 2022 Filed Feb 10, 2023 21:20 UTC | Biomea Fusion, Inc. BMEA · Entity 6606 | GiftCommon Stock | 4,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-23-004578 · doc5.xml · nonDerivative · entry 9 Erdtmann Rainer M · CIK 0001455767 · Director · President & COO 10b5-1 filing: Not disclosed Ownership: Indirect · By son Disclosed balance after: 7,000 Read SEC document |
| December 28, 2022 Filed Feb 10, 2023 21:20 UTC | Biomea Fusion, Inc. BMEA · Entity 6606 | GiftCommon Stock | 4,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-23-004578 · doc5.xml · nonDerivative · entry 8 Erdtmann Rainer M · CIK 0001455767 · Director · President & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 804,027 F2 · ownership.direct: Includes 76,059 shares held directly by the Reporting Person and the remaining shares are held directly by the Reporting Person through a family trust of which the Reporting Person is the trustee. The Reporting Person disclaims beneficial ownership of the securities reported herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of his pecuniary interest therein, if any. This report shall not be deemed an admission that the Reporting Person is a beneficial owner of such securities for the purpose of Section 16 of the Exchange Act, or for any other purpose. Read SEC document |
| December 28, 2022 Filed Feb 10, 2023 21:20 UTC | Biomea Fusion, Inc. BMEA · Entity 6606 | GiftCommon Stock | 4,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-23-004578 · doc5.xml · nonDerivative · entry 7 Erdtmann Rainer M · CIK 0001455767 · Director · President & COO 10b5-1 filing: Not disclosed Ownership: Indirect · By daughter Disclosed balance after: 7,000 Read SEC document |
| December 28, 2022 Filed Feb 10, 2023 21:20 UTC | Biomea Fusion, Inc. BMEA · Entity 6606 | GiftCommon Stock | 4,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-23-004578 · doc5.xml · nonDerivative · entry 6 Erdtmann Rainer M · CIK 0001455767 · Director · President & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 808,027 F2 · ownership.direct: Includes 76,059 shares held directly by the Reporting Person and the remaining shares are held directly by the Reporting Person through a family trust of which the Reporting Person is the trustee. The Reporting Person disclaims beneficial ownership of the securities reported herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of his pecuniary interest therein, if any. This report shall not be deemed an admission that the Reporting Person is a beneficial owner of such securities for the purpose of Section 16 of the Exchange Act, or for any other purpose. Read SEC document |
| December 28, 2022 Filed Feb 10, 2023 21:20 UTC | Biomea Fusion, Inc. BMEA · Entity 6606 | GiftCommon Stock | 4,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-23-004578 · doc5.xml · nonDerivative · entry 5 Erdtmann Rainer M · CIK 0001455767 · Director · President & COO 10b5-1 filing: Not disclosed Ownership: Indirect · By daughter Disclosed balance after: 6,400 Read SEC document |
| December 28, 2022 Filed Feb 10, 2023 21:20 UTC | Biomea Fusion, Inc. BMEA · Entity 6606 | GiftCommon Stock | 4,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-23-004578 · doc5.xml · nonDerivative · entry 4 Erdtmann Rainer M · CIK 0001455767 · Director · President & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 812,027 F2 · ownership.direct: Includes 76,059 shares held directly by the Reporting Person and the remaining shares are held directly by the Reporting Person through a family trust of which the Reporting Person is the trustee. The Reporting Person disclaims beneficial ownership of the securities reported herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of his pecuniary interest therein, if any. This report shall not be deemed an admission that the Reporting Person is a beneficial owner of such securities for the purpose of Section 16 of the Exchange Act, or for any other purpose. Read SEC document |
| August 19, 2022 Filed Feb 10, 2023 21:20 UTC | Biomea Fusion, Inc. BMEA · Entity 6606 | GiftCommon Stock | 16,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-23-004578 · doc5.xml · nonDerivative · entry 3 Erdtmann Rainer M · CIK 0001455767 · Director · President & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 816,027 F2 · ownership.direct: Includes 76,059 shares held directly by the Reporting Person and the remaining shares are held directly by the Reporting Person through a family trust of which the Reporting Person is the trustee. The Reporting Person disclaims beneficial ownership of the securities reported herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of his pecuniary interest therein, if any. This report shall not be deemed an admission that the Reporting Person is a beneficial owner of such securities for the purpose of Section 16 of the Exchange Act, or for any other purpose. Read SEC document |
| August 16, 2022 Filed Feb 10, 2023 21:20 UTC | Biomea Fusion, Inc. BMEA · Entity 6606 | GiftCommon Stock | 17,100 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-23-004578 · doc5.xml · nonDerivative · entry 2 Erdtmann Rainer M · CIK 0001455767 · Director · President & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 832,027 F2 · ownership.direct: Includes 76,059 shares held directly by the Reporting Person and the remaining shares are held directly by the Reporting Person through a family trust of which the Reporting Person is the trustee. The Reporting Person disclaims beneficial ownership of the securities reported herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of his pecuniary interest therein, if any. This report shall not be deemed an admission that the Reporting Person is a beneficial owner of such securities for the purpose of Section 16 of the Exchange Act, or for any other purpose. Read SEC document |
| July 01, 2022 Filed Feb 10, 2023 21:20 UTC | Biomea Fusion, Inc. BMEA · Entity 6606 | GiftCommon Stock | 100,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-23-004578 · doc5.xml · nonDerivative · entry 1 Erdtmann Rainer M · CIK 0001455767 · Director · President & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 849,127 F1 · balance_after: Includes 873,068 shares received prior to the gift in a distribution-in-kind, without consideration, from Biomea Health, LLC made in accordance with the exemptions afforded by Rule 16a-13 and Rule 16a-9 of the Securities Exchange Act of 1934, as amended. F2 · ownership.direct: Includes 76,059 shares held directly by the Reporting Person and the remaining shares are held directly by the Reporting Person through a family trust of which the Reporting Person is the trustee. The Reporting Person disclaims beneficial ownership of the securities reported herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of his pecuniary interest therein, if any. This report shall not be deemed an admission that the Reporting Person is a beneficial owner of such securities for the purpose of Section 16 of the Exchange Act, or for any other purpose. Read SEC document |
| December 04, 2021 Filed Dec 7, 2021 22:26 UTC | Biomea Fusion, Inc. BMEA · Entity 6606 | GrantStock Option (Right to Buy) · Derivative | 165,490 | $0.00 Strike: $9.80 | $0.00 |
DisclosureSEC source: 0001567619-21-021721 · doc1.xml · derivative · entry 5 Erdtmann Rainer M · CIK 0001455767 · Director · President & COO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 165,490 Underlying: Common Stock · 165,490 shares Expires 2031-12-03 F4 · derivative.exercise_date: The option shall vest and become exercisable in quarterly installments over four years, subject to the Reporting Person's continued service to the Issuer through each vesting date. Read SEC document |
| August 23, 2021 Filed Aug 26, 2021 00:56 UTC | Biomea Fusion, Inc. BMEA · Entity 6606 | PurchaseCommon Stock | 24,000 | $13.20 | $316,872.00 |
DisclosureSEC source: 0001567619-21-016342 · doc1.xml · nonDerivative · entry 1 Erdtmann Rainer M · CIK 0001455767 · Director · President & COO · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 228,470 F1 · ownership.nature: The shares are held directly by Point Sur Investors Fund I, LP ("Point Sur LP"). The General Partner of Point Sur LP is Point Sur Investors LLC. Rainer M Erdtmann and Thomas Butler are the managing members of Point Sur Investors, LLC and as such have voting and dispositive power over the securities held by Point Sur LP. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein. Read SEC document |
| August 18, 2021 Filed Aug 20, 2021 01:41 UTC | Biomea Fusion, Inc. BMEA · Entity 6606 | PurchaseCommon Stock | 14,000 | $10.77 | $150,738.00 |
DisclosureSEC source: 0001567619-21-016160 · doc1.xml · nonDerivative · entry 3 Erdtmann Rainer M · CIK 0001455767 · Director · President & COO · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 204,470 F1 · ownership.nature: The shares are held directly by Point Sur Investors Fund I, LP ("Point Sur LP"). The General Partner of Point Sur LP is Point Sur Investors LLC. Rainer M Erdtmann and Thomas Butler are the managing members of Point Sur Investors, LLC and as such have voting and dispositive power over the securities held by Point Sur LP. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein. Read SEC document |
| August 17, 2021 Filed Aug 20, 2021 01:41 UTC | Biomea Fusion, Inc. BMEA · Entity 6606 | PurchaseCommon Stock | 14,000 | $10.79 | $151,067.00 |
DisclosureSEC source: 0001567619-21-016160 · doc1.xml · nonDerivative · entry 2 Erdtmann Rainer M · CIK 0001455767 · Director · President & COO · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 190,470 F1 · ownership.nature: The shares are held directly by Point Sur Investors Fund I, LP ("Point Sur LP"). The General Partner of Point Sur LP is Point Sur Investors LLC. Rainer M Erdtmann and Thomas Butler are the managing members of Point Sur Investors, LLC and as such have voting and dispositive power over the securities held by Point Sur LP. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein. Read SEC document |
| April 15, 2021 Filed Aug 20, 2021 01:41 UTC | Biomea Fusion, Inc. BMEA · Entity 6606 | PurchaseCommon Stock | 176,470 | $17.00 | $2,999,990.00 |
DisclosureSEC source: 0001567619-21-016160 · doc1.xml · nonDerivative · entry 1 Erdtmann Rainer M · CIK 0001455767 · Director · President & COO · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 176,470 F1 · ownership.nature: The shares are held directly by Point Sur Investors Fund I, LP ("Point Sur LP"). The General Partner of Point Sur LP is Point Sur Investors LLC. Rainer M Erdtmann and Thomas Butler are the managing members of Point Sur Investors, LLC and as such have voting and dispositive power over the securities held by Point Sur LP. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein. Read SEC document |
| April 15, 2021 Filed Feb 10, 2023 21:10 UTC Amendment | Biomea Fusion, Inc. BMEA · Entity 6606 | PurchaseCommon Stock | 3,000 | $17.00 | $51,000.00 |
DisclosureSEC source: 0000899243-23-004569 · doc4a.xml · nonDerivative · entry 3 Erdtmann Rainer M · CIK 0001455767 · Director · President and COO · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By son Disclosed balance after: 3,000 Read SEC document |
| April 15, 2021 Filed Feb 10, 2023 21:10 UTC Amendment | Biomea Fusion, Inc. BMEA · Entity 6606 | PurchaseCommon Stock | 3,000 | $17.00 | $51,000.00 |
DisclosureSEC source: 0000899243-23-004569 · doc4a.xml · nonDerivative · entry 2 Erdtmann Rainer M · CIK 0001455767 · Director · President and COO · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By daughter Disclosed balance after: 3,000 Read SEC document |
| April 15, 2021 Filed Feb 10, 2023 21:10 UTC Amendment | Biomea Fusion, Inc. BMEA · Entity 6606 | PurchaseCommon Stock | 2,400 | $17.00 | $40,800.00 |
DisclosureSEC source: 0000899243-23-004569 · doc4a.xml · nonDerivative · entry 1 Erdtmann Rainer M · CIK 0001455767 · Director · President and COO · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By daughter Disclosed balance after: 2,400 Read SEC document |
| February 19, 2021 Filed Feb 23, 2021 23:01 UTC | Summit Therapeutics Inc. SMMT · Entity 3477 | GrantStock Option (right to buy) · Derivative | 25,000 | Not disclosed Strike: $7.33 | Not disclosed |
DisclosureSEC source: 0000921895-21-000544 · form412566erd_02232021.xml · derivative · entry 1 Erdtmann Rainer M · CIK 0001455767 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 252,273 Underlying: Common Stock · 25,000 shares Expires 2031-02-19 F2 · price: Not applicable. F1 · derivative.exercise_date: The option was granted on February 19, 2021. The shares underlying the option are scheduled to vest in full on December 31, 2021. Read SEC document |
| January 02, 2020 Filed Jan 6, 2020 16:05 UTC | POLARITYTE, INC. PTE · Entity 117561 | GrantStock option(Right to Buy) · Derivative | 38,437 | $2.08 Strike: $2.60 | $79,948.96 |
DisclosureSEC source: 0001493152-20-000213 · ownership.xml · derivative · entry 1 Erdtmann Rainer M · CIK 0001455767 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,437 Underlying: Common Stock · 38,437 shares Expires 2030-01-31 F1 · price: This option was issued to the reporting person pursuant to the 2019 Equity Incentive Plan for annual director fees in the amount of $80,000. Read SEC document |
| December 16, 2019 Filed Dec 17, 2019 16:30 UTC | POLARITYTE, INC. PTE · Entity 117561 | SaleCommon Stock | 31,846 | $2.47 | $78,659.62 |
DisclosureSEC source: 0001493152-19-019367 · ownership.xml · nonDerivative · entry 1 Erdtmann Rainer M · CIK 0001455767 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Zeigeist Inc. Disclosed balance after: 30,000 F1 · shares: Mr. Erdtmann owns and controls Zeigeist LLC. Zeigeist is a limited partner in Point Sur Investors Fund I, LP, a biotech investment fund, which sold its entire position in the common stock of the Issuer in accordance with Point Sur's investment policies. The number of shares sold is the portion of shares sold by Point Sur that were owned indirectly through Zeigeist. Zeitgeist still owns directly 30,000 shares and Mr. Erdtmann still owns 20,000 shares directly. F2 · price: The reported price is a weighted average price. The shares were sold in multiple transactions at prices ranging from $2.40 to $2.57, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price that was included in the calculation of tRheem warekigs:hted average price. Read SEC document |
| August 16, 2019 Filed Aug 19, 2019 16:15 UTC | POLARITYTE, INC. PTE · Entity 117561 | GrantEmployee Stock Option (Right to Buy) · Derivative | 4,202 | $3.87 Strike: $4.59 | $16,249.13 |
DisclosureSEC source: 0001493152-19-013011 · ownership.xml · derivative · entry 1 Erdtmann Rainer M · CIK 0001455767 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,202 Underlying: Common Stock · 4,202 shares Expires 2029-08-16 F1 · price: This option was issued to the reporting person pursuant to the 2019 Equity Incentive Plan in lieu of director fees of $16,250. Read SEC document |
| March 31, 2019 Filed Apr 17, 2019 19:24 UTC | POLARITYTE, INC. PTE · Entity 117561 | GrantEmployee Stock Option (Right to Buy) · Derivative | 1,701 | $9.55 Strike: $10.70 | $16,244.55 |
DisclosureSEC source: 0001493152-19-005582 · ownership.xml · derivative · entry 1 Erdtmann Rainer M · CIK 0001455767 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,701 Underlying: Common Stock · 1,701 shares Expires 2029-03-30 F1 · price: This option was issued to the reporting person pursuant to the 2019 Equity Incentive Plan in lieu of director fees of $16,250. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.